当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS杂志
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
基本信息
期刊名称 EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
EUR J PHARM BIOPHARM
期刊ISSN 0939-6411
期刊官方网站 http://www.elsevier.com/wps/find/journaldescription.cws_home/600120/description
是否OA
出版商 Elsevier
出版周期 Bimonthly
始发年份 1991
年文章数 317
最新影响因子 4.9(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学2区 PHARMACOLOGY & PHARMACY 药学2区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 5.25 1.326 1.503
Pharmacology, Toxicology and Pharmaceutics
Pharmaceutical Science
7 / 164 96%
Biochemistry, Genetics and Molecular Biology
Biotechnology
25 / 257 90%
补充信息
自引率 5.70%
H-index 138
SCI收录状况 Science Citation Index
Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0939-6411%5BISSN%5D
投稿指南
期刊投稿网址 http://ees.elsevier.com/ejpb/
收稿范围

The European Journal of Pharmaceutics and Biopharmaceutics provides a medium for the publication of novel, innovative and hypothesis-driven research from the areas of Pharmaceutics and Biopharmaceutics.

Topics covered include for example:

  • Design and development of drug delivery systems for pharmaceuticals and biopharmaceuticals (small molecules, proteins, nucleic acids)
  • Aspects of manufacturing process design
  • Biomedical aspects of drug product design
  • Strategies and formulations for controlled drug transport across biological barriers
  • Physicochemical aspects of drug product development
  • Novel excipients for drug product design
  • Drug delivery and controlled release systems for systemic and local applications
  • Nanomaterials for therapeutic and diagnostic purposes
  • Advanced therapy medicinal products
  • Medical devices supporting a distinct pharmacological effect



"The Rules of 3"

The Editors and Editorial board have developed the "Rules of 3". Authors must consider the following three criteria before they submit a manuscript and set the whole process of editing and reviewing at work:
1. The paper must report on novel findings that are not merely an unprecedented combination of known aspects in pharmaceutics and biopharmaceutics of major importance.
2. A paper must be based on a thorough and extensive study, using established or well-described methods and including proper controls. Research must be hypothesis-driven and conclusions must be supported by the data presented.
3. The study described in the manuscript must not merely confirm the state of the art in the field of pharmaceutics and biopharmaceutics, but advance it.


收录体裁
Research Papers
Review Articles
Short Reviews
Notes
投稿指南
投稿模板
参考文献格式
编辑信息
Editor-in-Chief
University of Regensburg Faculty of Chemistry and Pharmacy, Universitätsstrasse 31, 93040, Regensburg, Germany
Assistant Editor
University of Regensburg, Regensburg, Germany
Novartis AG, Utrecht, Netherlands
Editors

N. Bertrand

Laval University, Quebec, Canada

R. Brock

Radboudumc, Nijmegen, Netherlands

W. Friess

Ludwig Maximilians University Munich, Munich, Germany

H. W. Frijlink

University of Groningen, Groningen, Netherlands

J. Huwyler

University of Basel, Basel, Switzerland

G. Lee

Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany

C.-M. Lehr

Saarland University, Saarbruecken, Germany

M. Ogris

University of Vienna, Wien, Austria

T. Rades

University of Copenhagen Faculty of Health and Medical Sciences, København, Denmark

M.J. Rathbone

Universiti Perubatan Antarabangsa Malaysia, Kuala Lumpur, Malaysia

A. Schwendeman

University of Michigan, Ann Arbor, Michigan, United States
Editorial Board

V. Agrahari

CONRAD, Eastern Virginia Medical School (EVMS), Arlington, Virginia, United States

A. Aigner

Leipzig University, Leipzig, Germany

E. Allémann

University of Geneva Faculty of Science, Geneva, Switzerland

M.J. Alonso

Universidade de Santiago de Compostela Faculty of Pharmacy, Santiago de Compostela, Spain

J.-P. Benoit

University of Angers, Angers, France

A. Bernkop-Schnürch

University of Innsbruck, Innsbruck, Austria

M.J. Blanco-Prieto

University of Navarre Department of Technological Pharmacy and Pharmacy Chemistry, Pamplona, Spain

R. Bodmeier

Free University of Berlin Faculty of Biology Chemistry Pharmacology, Berlin, Germany

J. Breitkreutz

Heinrich Heine University Düsseldorf, Dusseldorf, Germany

H. Bunjes

Braunschweig University of Technology, Braunschweig, Germany

M. Capelle

Therapeomic AG, Riehen, Switzerland

U. Conte

University of Pavia, Pavia, Italy

L. Dailey

Martin Luther University Halle Wittenberg, Halle, Germany

R. Daniels

Eberhard Karls University Tübingen, Tubingen, Germany

F. Delie-Salmon

University of Geneva, Geneva, Switzerland

B. Demeule

Genentech Inc, South San Francisco, California, United States

J.-M. Devoisselle

Charles Gerhardt of Montpellier Institute, Montpellier, France

E. Doelker

University of Geneva, Geneva, Switzerland

P. Esposito

SiTec PharmaBio SL, Barcelona, Spain

E. Fattal

Paris-Sud University Faculty of Pharmacy, Chatenay Malabry, France

C. Fischbach-Teschl

Cornell University, Ithaca, New York, United States

G. Fricker

University of Heidelberg Institute of Pharmacy and Molecular Biotechnology, Heidelberg, Germany

A. Gazzaniga

University of Milan Department of Pharmaceutical Sciences, Milano, Italy

P. Gershkovich

University of Nottingham, Nottingham, United Kingdom

M.A. Gonzalez

P'Kinetics International Inc, Pembroke Pines, Florida, United States

R. Gref

Paris-Sud University Faculty of Pharmacy, Chatenay Malabry, France

R.H. Guy

University of Bath - Department of Pharmacy and Pharmacology, Bath, United Kingdom

M. Hacker

Leipzig University, Leipzig, Germany

J. Hadgraft

University College London School of Pharmacy, London, United Kingdom

J. Hanes

Johns Hopkins University Center for Nanomedicine, Baltimore, Maryland, United States

S. Hedtrich

The University of British Columbia, Vancouver, British Columbia, Canada

S. Hook

University of Otago, Dunedin, New Zealand

Y. N. Kalia

Pharmacy College Geneva-Lausanne, Geneva, Switzerland

T. Kissel

University of Marburg, Marburg, Germany

S. Klein

University of Greifswald, Greifswald, Germany

P. Kleinebudde

Heinrich Heine University Dusseldorf Institute for Pharmaceutical Technology and Biopharmacy, Düsseldorf, Germany

J. Kopecek

The University of Utah, Salt Lake City, Utah, United States

J. Kreuter

Goethe University Frankfurt, Frankfurt am Main, Germany

J. Kristl

University of Ljubljana, Ljubljana, Slovenia

S. Küchler

Free University of Berlin, Berlin, Germany

U. Lächelt

Ludwig Maximilian University Munich Chair of Pharmaceutical Biology Biotechnology, München, Germany

N. Lange

University of Geneva, Geneva, Switzerland

H. Lindner

Bayer Schering Pharma AG, Berlin, Germany

T. Lühmann

University of Würzburg, Wurzburg, Germany

K. Mäder

Martin Luther University Halle-Wittenberg Department of Pharmacy, Halle, Germany

E. Mathiowitz

Brown University, Providence, Rhode Island, United States

O. Merkel

Ludwig Maximilians University Munich, Munich, Germany

A.G. Mikos

Rice University, Houston, Texas, United States

D. Mooney

Harvard University Mooney Laboratory, Cambridge, Massachusetts, United States

C. Müller-Goymann

Braunschweig University of Technology, Braunschweig, Germany

R.H. Müller

Pharmaceutical Technology of Free University of Berlin, Berlin, Germany

T. Nagai

The Nagai Foundation Tokyo, Tokyo, Japan

R.H.H. Neubert

Martin Luther University Halle Wittenberg, Halle, Germany

A.F. Öner

Hacettepe University, Ankara, Turkey

N.A. Peppas

University of Texas at Austin Institute for Biomaterials Drug Delivery & Regenerative Medicine, Austin, Texas, United States

K. Remaut

Ghent University, Gent, Belgium

C. Rudolph

Ludwig Maximilians University Munich, Munich, Germany

I. Rupenthal

The University of Auckland Faculty of Medical and Health Sciences, Auckland, New Zealand

L. Scapozza

Pharmacy College Geneva-Lausanne, Geneva, Switzerland

R. Scherliess

Kiel University, Kiel, Germany

M. Schneider

University of Marburg, Marburg, Germany

R. Schubert

University of Freiburg, Freiburg im Breisgau, Germany

S.P. Schwendeman

University of Michigan Department of Pharmaceutical Sciences, Ann Arbor, Michigan, United States

J. Siepmann

University of Lille Faculty of Pharmacy, Lille cedex, France

S. Srčič

University of Ljubljana, Ljubljana, Slovenia

V. Torchilin

Northeastern University Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, Massachusetts, United States

C. Valenta

University of Vienna, Wien, Austria

M.G. Wacker

National University of Singapore Department of Pharmacy, Singapore, Singapore

E. Wagner

Ludwig Maximilian University Munich Chair of Pharmaceutical Biology Biotechnology, München, Germany

W. Weitschies

University of Greifswald Institute of Pharmacy, Greifswald, Germany

S. Wilhelm

The University of Oklahoma Stephenson School of Biomedical Engineering, Norman, Oklahoma, United States

C.G. Wilson

University of Strathclyde, Glasgow, Scotland, United Kingdom

G. Winter

Ludwig Maximilians University Munich, Munich, Germany

A. Zimmer

Graz University of Technology, Graz, Austria
Honorary Editor

R. Gurny

Pharmacy College Geneva-Lausanne, Geneva, Switzerland


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug